Assessment of phosphatidylinositol-3 kinase (PI3K) as a prognostic marker in head and neck squamous cell carcinoma (HNSCC)

被引：1
|
作者：
Pectasides, E.
Founztilas, G.
Sasaki, C.
Burtness, B.
Psyrri, A.
机构：
[1] Yale Univ, New Haven, CT USA
[2] Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece
[3] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17028
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Overcoming acquired resistance to PI3K inhibitors in head and neck squamous cell carcinoma with combination treatment
    Mizrachi, Aviram
    Dunn, Lara
    Ho, Alan
    Scaltriti, Maurizio
    CLINICAL CANCER RESEARCH, 2017, 23 (23)
  • [22] Role of PI3K/AKT pathway in squamous cell carcinoma with an especial focus on head and neck cancers
    Ghafouri-Fard, Soudeh
    Alamdari, Ali Noie
    Alamdari, Yashar Noee
    Abak, Atefe
    Hussen, Bashdar Mahmud
    Taheri, Mohammad
    Jamali, Elena
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [23] Identification of NOTCH1 inactivating mutation as a therapeutic vulnerability to PI3K/mTOR pathway inhibition in head and neck squamous cell carcinoma (HNSCC)
    Sambandam, Vaishnavi
    Shen, Li
    Tong, Pan
    Mazumdar, Tuhina
    Pickering, Curtis
    Myers, Jeffrey N.
    Wang, Jing
    Frederick, Mitchell
    Johnson, Faye M.
    CANCER RESEARCH, 2017, 77
  • [24] Phosphatidylinositol-3 kinase (PI3K)/Akt/mTOR pathway is activated in an in vitro model of HIV Encephalitis
    Akay, Cagla
    Chodroff, Rebecca A.
    Wang, Ying
    White, Michael G.
    Kolson, Dennis L.
    Jordan-Sciutto, Kelly L.
    JOURNAL OF NEUROVIROLOGY, 2006, 12 : 2 - 3
  • [25] STMN1, a prognostic predictor of esophageal squamous cell carcinoma, is a marker of the activation of the PI3K pathway
    Jiang, Wenpeng
    Huang, Shiting
    Song, Liang
    Wang, Zhou
    ONCOLOGY REPORTS, 2018, 39 (02) : 834 - 842
  • [26] Nanog promotes PI3K/Akt and mTOR-mediated invasion in head and neck squamous cell carcinoma
    Rahimy, Elham
    Yi, David
    Lew, Daniel
    Abhold, Eric
    Kiang, Alan
    Wang-Rodriguez, Jessica
    Ongkeko, Weg
    CANCER RESEARCH, 2012, 72
  • [27] Evaluation of predictive biomarkers and resistance mechanisms of PI3K pathway inhibition in head and neck squamous cell carcinoma
    Mazumdar, Tuhina
    Byers, Lauren A.
    Ng, Patrick
    Mills, Gordon B.
    Peng, Shaohua
    Diao, Lixia
    Fan, Youhong
    Stemke-Hale, Katherine
    Heymach, John V.
    Myers, Jeffrey N.
    Glisson, Bonnie S.
    Johnson, Faye M.
    CANCER RESEARCH, 2014, 74 (19)
  • [28] Morphine-induced cardioprotection requires activation of phosphatidylinositol-3 kinase (PI3k) and target of rapamycin (TOR)
    Gross, ER
    Hsu, AK
    Gross, GJ
    FASEB JOURNAL, 2003, 17 (04): : A229 - A230
  • [29] Novel age-associated induction of components of the phosphatidylinositol-3 kinase (PI3K)/Akt signaling in the intestine
    Murillo, C
    Evers, M
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2003, 197 (03) : S7 - S8
  • [30] Prognostic and predictive methylation biomarkers in HNSCC Epigenomic diagnostics for head and neck squamous cell carcinoma (HNSCC)
    Franzen, A.
    Bootz, F.
    Dietrich, D.
    HNO, 2020, 68 (12) : 911 - 915
12345